Annual Accounts Receivable
$9.01 M
-$78.00 K-0.86%
31 December 2023
Summary:
Poseida Therapeutics annual accounts receivable is currently $9.01 million, with the most recent change of -$78.00 thousand (-0.86%) on 31 December 2023. PSTX annual accounts receivable is now -0.86% below its all-time high of $9.09 million, reached on 31 December 2022.PSTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$14.75 M
+$2.32 M+18.69%
30 September 2024
Summary:
Poseida Therapeutics quarterly accounts receivable is currently $14.75 million, with the most recent change of +$2.32 million (+18.69%) on 30 September 2024. Over the past year, it has increased by +$6.08 million (+70.08%). PSTX quarterly accounts receivable is now -61.66% below its all-time high of $38.47 million, reached on 30 September 2022.PSTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | +70.1% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PSTX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.9% | -61.7% | ||
| 5 y | 5 years | -0.9% | -61.7% | ||
| alltime | all time | -0.9% | -61.7% |
Poseida Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.75 M(+18.7%) |
| June 2024 | - | $12.43 M(+3.3%) |
| Mar 2024 | - | $12.03 M(+33.5%) |
| Dec 2023 | $9.01 M | $9.01 M(+3.9%) |
| Sept 2023 | - | $8.67 M(-27.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $11.91 M(+41.1%) |
| Mar 2023 | - | $8.44 M(-7.2%) |
| Dec 2022 | $9.09 M(>+9900.0%) | $9.09 M(-76.4%) |
| Sept 2022 | - | $38.47 M(>+9900.0%) |
| June 2022 | - | $232.00 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Poseida Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Poseida Therapeutics?
- What is Poseida Therapeutics annual accounts receivable year-on-year change?
- What is Poseida Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly accounts receivable year-on-year change?
What is Poseida Therapeutics annual accounts receivable?
The current annual accounts receivable of PSTX is $9.01 M
What is the all time high annual accounts receivable for Poseida Therapeutics?
Poseida Therapeutics all-time high annual accounts receivable is $9.09 M
What is Poseida Therapeutics annual accounts receivable year-on-year change?
Over the past year, PSTX annual accounts receivable has changed by -$78.00 K (-0.86%)
What is Poseida Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of PSTX is $14.75 M
What is the all time high quarterly accounts receivable for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly accounts receivable is $38.47 M
What is Poseida Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, PSTX quarterly accounts receivable has changed by +$6.08 M (+70.08%)